Target Corporation (TGT)
Astria Therapeutics: Updating Target Price, Biocryst Deal Expected To Go Through, Hold
I maintain a hold rating on Astria Therapeutics with an updated $13 target price following Biocryst's announced acquisition, expecting a 90%+ chance of deal closure by Q1 2026. The investment thesis shifts from clinical catalyst to merger arbitrage, with strong strategic rationale for BCRX to acquire ATXS and minimal regulatory or financial barriers anticipated. Navenibart (STAR-0215) is viewed as a best-in-class prophylaxis agent, and the acquisition offers shareholders a liquidity event, mitigating phase 3 and competitive risks.
Target: Red Lights Flashing, Dividend Blinking -- Sell
Target Corporation (TGT) faces ongoing operational challenges, weak free cash flow, and a high debt load, putting its 57-year dividend streak at risk. TGT's core discretionary categories are in decline, with growth limited to lower-margin food and essentials, reflecting cautious consumer behavior and structural margin pressure. Rising Capex commitments and a dividend funding gap threaten the sustainability of TGT's payout, with management signaling no near-term turnaround in business dynamics.
Retailers Hype—and Hope for—a Busy Black Friday This Year
Brands are vying for the billions Americans are expected to spend the day after Thanksgiving.
Target bets on $5B store revamp plan to revive sales
Target announced a $5 billion investment to expand with larger stores and revamp existing locations despite ongoing sales challenges and market pressures.
Semiconductor Stock Pops on Upgrade, Price-Target Hike
Semiconductor stock Applied Materials Inc (NASDAQ:AMAT) is up 1.7% to trade at $235.81 at last check, on the heels of an upgrade to "buy" from "neutral" at UBS.
Can ChatGPT-Powered Shopping Drive Target's Next Digital Push?
TGT's new Gen-AI Gift Finder and upcoming ChatGPT shopping aim to boost digital engagement and drive its next growth phase.
Target Corporation (TGT) is Attracting Investor Attention: Here is What You Should Know
Target (TGT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
MP Materials Stock Upgraded, Price Target Cut. What It Says About Rare-Earths Plays.
BMO analyst Raj Ray upgraded shares of MP to Buy from Hold. His price target went down $1 to $75 a share.
Buy Target or Walmart Stock After Beating Q3 EPS Expectations?
Target (TGT) and Walmart (WMT) offered insight into the strength of the consumer in their Q3 reports this week, and both were able to pleasantly beat earnings expectations.
Should You Buy Target Stock After Its Q3 Earnings Release?
TGT's third-quarter results reveal soft demand, shrinking margins and a sliding stock, prompting investors to reassess the retailer's turnaround prospects.
Why Target Stock May Keep Falling Despite a 5% Dividend Yield
Target NYSE: TGT is trading in deep-value territory, offering a projected 5% dividend yield in late 2025, but that alone may not be enough reason to buy in. Despite some potential for recovery in 2026, near-term headwinds remain strong.
Target Has a New Idea for For Spotting Trends: It's Asking AI.
Target is trying a new trick for tapping trends: asking AI.
